Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
Inspire Medical Systems (NYSE: INSP) announced its management team will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 12:45 p.m. Eastern Time.
The presentation will be available via a live webcast, with a replay accessible for two weeks after the event in the Event Archive on Inspire’s investor website: https://investors.inspiresleep.com.
Positive
- None.
Negative
- None.
News Market Reaction – INSP
In the Dec 29 session, INSP declined 1.89%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Nov 18 | Conference appearance | Neutral | -1.5% | Announcement of Piper Sandler healthcare conference presentation and webcast access. |
| Nov 03 | Earnings results | Positive | +2.3% | Q3 2025 results with revenue growth, high gross margin, and raised EPS guidance. |
| Oct 27 | Conference appearance | Neutral | +0.9% | UBS Global Healthcare Conference presentation and webcast details for investors. |
| Oct 10 | Clinical data update | Positive | -6.2% | Inspire V clinical data showing improved IPOP, shorter surgery, and AHI reductions. |
| Oct 06 | Earnings call timing | Neutral | -0.3% | Scheduling of Q3 2025 earnings release and conference call logistics. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings and major data updates have sometimes produced outsized moves, while routine conference presentations have generally coincided with modest price changes, occasionally negative.
Over the last few months, Inspire Medical Systems reported Q3 2025 revenue of $224.5M with reaffirmed 2025 guidance and share repurchases, which was followed by a modest positive price reaction. Clinical data for the Inspire V system released in October 2025 showed stronger efficacy and shorter surgical time yet coincided with a notable negative move. Multiple conference and presentation announcements, including UBS and Piper Sandler, produced relatively small price reactions. Today’s J.P. Morgan conference appearance continues this pattern of investor-relations outreach.
Key Terms
obstructive sleep apnea medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
MINNEAPOLIS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026.
Inspire is scheduled to present at 12:45 p.m. Eastern Time. The presentation will be accessible via a live webcast here.
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
